Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical studies and accepted therapies of advanced melanoma].

Magyar onkologia - 2 Mar 2016

Liszkay Gabriella

Abstract excerpt

The objective of the work is presentation of the available therapeutic results of the clinical trials with anti CTLA-4 and anti PD-1 treatment, which are operating on the immune checkpoints registered in advanced melanoma, and the results of T-VEC vaccination (NCT00094653, NCT00324155, KEYNOTE-001, -002, -006, CheckMate-066, -037, -067, NCT00769704). With ipilimumab therapy, long-term survival can be achieved in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Ipilimumab

Share to Melanoma

Share to Skin Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 26934345

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical studies and accepted therapies of advanced melanoma].PMID 26934345Read ↗

[Molecular-target therapy for advanced malignant melanoma].Semantic proximity Read ↗

[Guidelines for stage I to III melanoma].Semantic proximity Read ↗

[Paradigmatic shift in oncology: individualized melanoma treatment].Semantic proximity Read ↗

[Melanoma: from molecular studies to the treatment breakthrough].Semantic proximity Read ↗

[Melanoma and search for therapeutic targets].Semantic proximity Read ↗

Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.Semantic proximity Read ↗

French updated recommendations in Stage I to III melanoma treatment and management.Semantic proximity Read ↗

Melanoma.Semantic proximity Read ↗

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.Semantic proximity Read ↗

Immunotherapy in Melanoma: A Dynamic Frontier in Cancer Treatment : Author List.Semantic proximity Read ↗

[Genetic diversity and immunological characteristics of malignant melanoma: the therapeutic spectrum].Semantic proximity Read ↗

Emerging targeted therapies for melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.